FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361948931> ?p ?o ?g. }

• W4361948931 abstract "<div>Abstract<p><b>Background:</b> In the Women's Health Initiative Hormone Trials (WHI-HT), breast cancer risk was increased with estrogen plus progestin (E+P) but not with unopposed estrogen (E-alone). We hypothesized that E+P would preferentially metabolize to 16α-hydroxyestrone (16α-OHE1) rather than 2-hydroxyestrone (2-OHE1), and that breast cancer risk would be associated with baseline and 1 year changes in estrogen metabolites: positively for 16α-OHE1 levels and negatively for levels of 2-OHE-1 and the 2:16 ratio.</p><p><b>Methods:</b> In a prospective case-control study nested in the WHI-HT, 845 confirmed breast cancer cases were matched to 1,690 controls by age and ethnicity. Using stored serum, 2-OHE1 and 16α-OHE1 levels were measured by enzyme immunoassay at baseline, and for those randomized to active treatment (<i>n</i> = 1,259), at 1 year.</p><p><b>Results:</b> The 1-year increase in 16α-OHE1 was greater with E+P than E-alone (median 55.5 pg/mL vs. 43.5 pg/mL, <i>P</i> < 0.001), but both increased 2-OHE1 by ∼300 pg/mL. Breast cancer risk was modestly associated with higher baseline levels of 2-OHE1 and the 2:16 ratio, and for estrogen receptor+/progesterone+ cases only, higher baseline 16α-OHE1 levels. For those randomized to active treatment, breast cancer risk was associated with greater increase in 2-OHE-1 and the 2:16 ratio, but associations were not significant.</p><p><b>Conclusions:</b> Although E+P modestly increased 16α-OHE1 more than E-alone, increase in 16α-OHE1 was not associated with breast cancer.</p><p><b>Impact:</b> Study results do not explain differences between the WHI E+P and WHI E-alone breast cancer results but metabolism of oral HT, which may explain smaller than expected increase in breast cancer compared with endogenous estrogens. <i>Cancer Epidemiol Biomarkers Prev; 21(11); 2022–32. ©2012 AACR</i>.</p></div>" @default.
• W4361948931 created "2023-04-05" @default.
• W4361948931 creator A5004840750 @default.
• W4361948931 creator A5008504819 @default.
• W4361948931 creator A5025402303 @default.
• W4361948931 creator A5033390974 @default.
• W4361948931 creator A5037795621 @default.
• W4361948931 creator A5049411008 @default.
• W4361948931 creator A5056675909 @default.
• W4361948931 creator A5067190037 @default.
• W4361948931 creator A5076251961 @default.
• W4361948931 creator A5083711172 @default.
• W4361948931 creator A5087916636 @default.
• W4361948931 creator A5090824996 @default.
• W4361948931 date "2023-03-31" @default.
• W4361948931 modified "2023-09-26" @default.
• W4361948931 title "Data from Hormone Therapy, Estrogen Metabolism, and Risk of Breast Cancer in the Women's Health Initiative Hormone Therapy Trial" @default.
• W4361948931 doi "https://doi.org/10.1158/1055-9965.c.6516027.v1" @default.
• W4361948931 hasPublicationYear "2023" @default.
• W4361948931 type Work @default.
• W4361948931 citedByCount "0" @default.
• W4361948931 crossrefType "posted-content" @default.
• W4361948931 hasAuthorship W4361948931A5004840750 @default.
• W4361948931 hasAuthorship W4361948931A5008504819 @default.
• W4361948931 hasAuthorship W4361948931A5025402303 @default.
• W4361948931 hasAuthorship W4361948931A5033390974 @default.
• W4361948931 hasAuthorship W4361948931A5037795621 @default.
• W4361948931 hasAuthorship W4361948931A5049411008 @default.
• W4361948931 hasAuthorship W4361948931A5056675909 @default.
• W4361948931 hasAuthorship W4361948931A5067190037 @default.
• W4361948931 hasAuthorship W4361948931A5076251961 @default.
• W4361948931 hasAuthorship W4361948931A5083711172 @default.
• W4361948931 hasAuthorship W4361948931A5087916636 @default.
• W4361948931 hasAuthorship W4361948931A5090824996 @default.
• W4361948931 hasConcept C121608353 @default.
• W4361948931 hasConcept C126322002 @default.
• W4361948931 hasConcept C134018914 @default.
• W4361948931 hasConcept C2776607906 @default.
• W4361948931 hasConcept C2777164284 @default.
• W4361948931 hasConcept C2780275930 @default.
• W4361948931 hasConcept C2780733421 @default.
• W4361948931 hasConcept C3018603563 @default.
• W4361948931 hasConcept C530470458 @default.
• W4361948931 hasConcept C71924100 @default.
• W4361948931 hasConceptScore W4361948931C121608353 @default.
• W4361948931 hasConceptScore W4361948931C126322002 @default.
• W4361948931 hasConceptScore W4361948931C134018914 @default.
• W4361948931 hasConceptScore W4361948931C2776607906 @default.
• W4361948931 hasConceptScore W4361948931C2777164284 @default.
• W4361948931 hasConceptScore W4361948931C2780275930 @default.
• W4361948931 hasConceptScore W4361948931C2780733421 @default.
• W4361948931 hasConceptScore W4361948931C3018603563 @default.
• W4361948931 hasConceptScore W4361948931C530470458 @default.
• W4361948931 hasConceptScore W4361948931C71924100 @default.
• W4361948931 hasLocation W43619489311 @default.
• W4361948931 hasOpenAccess W4361948931 @default.
• W4361948931 hasPrimaryLocation W43619489311 @default.
• W4361948931 hasRelatedWork W1967719934 @default.
• W4361948931 hasRelatedWork W1978926508 @default.
• W4361948931 hasRelatedWork W2063985027 @default.
• W4361948931 hasRelatedWork W2081262273 @default.
• W4361948931 hasRelatedWork W2109968954 @default.
• W4361948931 hasRelatedWork W2125066659 @default.
• W4361948931 hasRelatedWork W2162449142 @default.
• W4361948931 hasRelatedWork W2163099211 @default.
• W4361948931 hasRelatedWork W2171533518 @default.
• W4361948931 hasRelatedWork W4281253185 @default.
• W4361948931 isParatext "false" @default.
• W4361948931 isRetracted "false" @default.
• W4361948931 workType "article" @default.